Literature DB >> 7507461

Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis.

M Tsutsumi1, S Urashima, A Takada, T Date, Y Tanaka.   

Abstract

Hepatitis C virus is a positive single-strand RNA virus distantly related to flaviviruses. Therefore RNA replicase, an RNA-dependent RNA polymerase, may be essential for the replication of hepatitis C virus, as well as other RNA viruses. In this study we synthesized the recombinant polypeptide (HCV-NS5 antigen) with a 576 bp cDNA encoding a part of the NS5 region of the HCV genome that has the Gly-Asp-Asp motif. The antibody against this polypeptide was obtained from rabbit serum. In Western-blot analysis with NS5 IgG HCV antibody, an 84-kD protein was clearly detected as a single band in the microsomal fraction but not in the nuclear and mitochondrial fractions or in the cytosol fraction. Immunohistochemically, HCV-NS5 antigen was clearly stained in the cytoplasm of hepatocytes but not in the nucleus or cell membrane. Moreover, as determined on immunoelectron microscopy, HCV-NS5 antigen was demonstrated with fine granular distribution along the endoplasmic reticulum but not in other organelles, including the nucleus and mitochondria. Immunoreaction in other cell types was negative. These results indicate that replication of HCV may occur only in hepatocytes and that HCV-NS5 may be produced in the endoplasmic reticulum of these cells. HCV-NS5 antigen was stained only in the livers of hepatitis C virus-positive patients but not in sections from patients with chronic type B hepatitis or alcoholic fibrosis. In chronic type C liver disease, the overall detection rate of HCV-NS5 antigen was 56% (33% in chronic persistent hepatitis, 52% in chronic active hepatitis and 86% in cirrhosis).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507461

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Localization of HCV RNA and capsid protein in human hepatocellular carcinoma.

Authors:  Yi-Ming Dai; Zhi-Ping Shou; Can-Rong Ni; Neng-Jin Wang; Song-Ping Zhang
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  A comparison between previous and present histologic assessments of chronic hepatitis C viral infections in humans.

Authors:  N Assy; GY Minuk
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

Review 3.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

4.  In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease.

Authors:  M Chang; A P Marquardt; B L Wood; O Williams; S J Cotler; S L Taylor; R L Carithers; D R Gretch
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity.

Authors:  S I Khakoo; P N Soni; K Savage; D Brown; A P Dhillon; L W Poulter; G M Dusheiko
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

6.  Pathomorphological Characteristics and Pathogenesis of Viral Hepatitis.

Authors:  Zsuzsa Schaff; Gábor Lotz; Rolf Schulte-Herman
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 7.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

8.  Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C.

Authors:  R P González-Peralta; J W Fang; G L Davis; R G Gish; M Kohara; M U Mondelli; M S Urdea; M Mizokami; J Y Lau
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

9.  Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.

Authors:  G Ballardini; P Groff; P Pontisso; F Giostra; R Francesconi; M Lenzi; D Zauli; A Alberti; F B Bianchi
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  Preparation and application of monoclonal antibodies against hepatitis C virus nonstructural proteins.

Authors:  J E Gao; Q M Tao; J P Guo; H P Ji; Z W Lang; Y Ji; B F Feng
Journal:  World J Gastroenterol       Date:  1997-06-15       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.